4.6 Review

Cognitive impairment in people with previous COVID-19 infection: A scoping review

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Prevalence of post-traumatic stress disorder among survivors of severe COVID-19 infections: A systematic review and meta-analysis

Ramya Nagarajan et al.

Summary: This study investigated the prevalence of PTSD among severe cases of COVID-19, finding a prevalence rate of 16%. Significant variation in prevalence rates between regions was observed, indicating a need for region-specific interventions to address PTSD risks following severe COVID-19 infection.

JOURNAL OF AFFECTIVE DISORDERS (2022)

Article Clinical Neurology

Episodic long-term memory in post-infectious SARS-CoV-2 patients

Edoardo Nicolo Aiello et al.

Summary: Episodic long-term memory deficits are common in COVID-19-recovered patients, with both primary and secondary etiology possibly playing a role. Screening for these deficits is important, especially in patients with moderate-to-severe COVID-19 and those already at risk for cognitive decline. Different measures of verbal LTM can be used, with the I-level measures potentially being more sensitive.

NEUROLOGICAL SCIENCES (2022)

Article Clinical Neurology

Cognitive, behavioral, and psychological manifestations of COVID-19 in post-acute rehabilitation setting: preliminary data of an observational study

Silvia Bonizzato et al.

Summary: This study aimed to verify the effectiveness of an assessment model for patients with COVID-19, showing qualitative improvements in neuropsychological assessment results. A significant variation in AD-R depression score was found in the three months follow-up evaluation. Evaluating and tracking the impact of COVID-19 on cognitive, psychological, and behavioral domains is crucial for rehabilitation and long-term assistance planning.

NEUROLOGICAL SCIENCES (2022)

Review Clinical Neurology

Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis

James B. Badenoch et al.

Summary: The prevalence and persistence of neuropsychiatric symptoms after COVID-19 infection are high. Insomnia, fatigue, cognitive impairment, anxiety, post-traumatic symptoms, and mood disorders are the most common symptoms experienced by survivors. Multidisciplinary healthcare services are necessary for COVID-19 survivors.

BRAIN COMMUNICATIONS (2022)

Article Clinical Neurology

Neurologic and cognitive sequelae after SARS-CoV2 infection: Different impairment for ICU patients

Flavia Mattioli et al.

Summary: This study investigates the types of neurological and cognitive impairment in COVID-19 cases of different severity. The results show that patients treated in ICU perform significantly worse in neuropsychological tests and have a higher level of cognitive impairment. These findings support the greater susceptibility of COVID-19 patients in ICU to develop neurological deficits and cognitive impairment at a four-month follow-up.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2022)

Article Rehabilitation

Neuropsychological Features of Severe Hospitalized Coronavirus Disease 2019 Patients at Clinical Stability and Clues for Postacute Rehabilitation

Francesco Negrini et al.

Summary: The study found that some COVID-19 patients might experience global cognitive decay, which is linearly associated with the length of stay in the ICU. Therefore, neuropsychological rehabilitative treatments should be directed explicitly toward ICU patients, rather than every patient who experienced acute respiratory distress syndrome due to COVID-19.

ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2021)

Article Immunology

Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up

Mazza Mario Gennaro et al.

Summary: The mental health implications and cognitive status of COVID-19 pneumonia survivors were prospectively evaluated one and three months after hospital discharge. 35.8% of patients still self-rated symptoms in the clinical range in at least one psychopathological dimension at three months post-discharge. Baseline systemic immune-inflammation index predicted self-rated depressive symptomatology and cognitive impairment at three-months follow-up.

BRAIN BEHAVIOR AND IMMUNITY (2021)

Article Clinical Neurology

Intracortical GABAergic dysfunction in patients with fatigue and dysexecutive syndrome after COVID-19

Viviana Versace et al.

Summary: The study revealed reduced GABAergic inhibition in the primary motor cortex of patients who recovered from COVID-19 with neurological complications, presenting fatigue and executive function syndrome. TMS may serve as a diagnostic tool for assessing cognitive disturbances and fatigue in post-COVID-19 patients.

CLINICAL NEUROPHYSIOLOGY (2021)

Article Clinical Neurology

Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: A longitudinal prospective study nested to a population cohort

Oscar H. Del Brutto et al.

Summary: This study provides evidence of cognitive decline among individuals with mild symptomatic SARS-CoV-2 infection. The pathogenesis of this complication remains unknown. Seropositive individuals were found to have a higher risk of cognitive decline compared to seronegative individuals.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Article Neurosciences

Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19

Abhishek Jaywant et al.

Summary: Most COVID-19 patients who require acute rehabilitation prior to discharge exhibit cognitive impairment, with deficits commonly seen in working memory, set-shifting, divided attention, and processing speed. Interventions targeting attention and executive dysfunctions may be beneficial for this population.

NEUROPSYCHOPHARMACOLOGY (2021)

Article Multidisciplinary Sciences

COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience

Federica Alemanno et al.

Summary: Neurological, psychiatric, and psychological impairments are common complications of COVID-19. A study on the cognitive functions of patients in the sub-acute phase of the disease found that 80% of patients had neuropsychological deficits and 40% showed signs of mild-to-moderate depression. Cognitive impairments were correlated with patients' age, and a significant percentage of patients showed signs of post-traumatic stress disorder one month after discharge.

PLOS ONE (2021)

Article Clinical Neurology

Cognitive impairment and a ered cerebral glucose metabolism in the subacute stage of COVID-19

Jonas A. Hosp et al.

Summary: During the COVID-19 pandemic, a prospective cohort study investigated neurological and cognitive symptoms in hospitalized patients, revealing that gustation and olfaction were commonly affected, along with cognitive impairment. Abnormalities in neuronal metabolism were associated with cognitive decline, highlighting the importance of neurological monitoring in COVID-19 patients.

BRAIN (2021)

Article Geriatrics & Gerontology

Hyposmia Is Associated with Reduced Cognitive Function in COVID-19: First Preliminary Results

Agnes Pirker-Kees et al.

Summary: The study found that olfactory dysfunction is associated with cognitive impairment in both mild COVID-19 patients and controls. Olfactory dysfunction may serve as a potentially useful clinical biomarker for subtle and even subclinical neurological involvement in severe acute respiratory distress syndrome coronavirus-2 infection.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2021)

Article Clinical Neurology

Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables

K. W. Miskowiak et al.

Summary: This study investigated the frequency, pattern, and severity of cognitive impairments in patients 3-4 months after COVID-19 hospital discharge, finding that a majority of patients had clinically significant cognitive impairment. These impairments were associated with subjective cognitive complaints, lower quality of life, and illness variables. Further research is needed to understand the associations between cognitive sequelae of COVID-19 and lung affection, cerebral oxygen delivery, and targeted treatments for persistent cognitive impairments.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2021)

Article Medicine, General & Internal

Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19

Luc Morin et al.

Summary: After 4 months of hospitalization for COVID-19, a significant proportion of patients reported new symptoms and abnormalities in lung scans were common. Further research is needed to understand the long-term consequences of COVID-19.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Clinical Neurology

Neurological and cognitive sequelae of Covid-19: a four month follow-up

Flavia Mattioli et al.

Summary: The study aimed to investigate whether objective neurological or cognitive impairment could be detected in COVID-19 patients four months after infection. The results showed that most patients had normal neurological examination and cognitive evaluation, but anxiety, stress, and depression scores were significantly higher in COVID-19 cases compared to the non-COVID-19 group.

JOURNAL OF NEUROLOGY (2021)

Article Clinical Neurology

What's going on following acute covid-19? Clinical characteristics of patients in an out-patient rehabilitation program

Sergiu Albu et al.

Summary: This study characterized post-COVID-19 sequelae and persistent symptoms in patients undergoing outpatient rehabilitation, finding that the main reasons for referral were fatigue, dyspnea, cognitive impairment, and neurological sequelae. The impact of persistent symptoms on daily life activities and quality of life was high, indicating the need for rehabilitation regardless of acute infection severity.

NEUROREHABILITATION (2021)

Article Clinical Neurology

Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 long haulers

Edith L. Graham et al.

Summary: This study investigated the neurologic manifestations in non-hospitalized Covid-19 long haulers, revealing prominent symptoms such as brain fog and fatigue which negatively affect their cognition and quality of life.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

Review Clinical Neurology

Neuropathological findings from COVID-19 patients with neurological symptoms argue against a direct brain invasion of SARS-CoV-2: A critical systematic review

Giuseppe Cosentino et al.

Summary: Neuropathological studies in COVID-19 patients reveal that neurological symptoms are associated with brain inflammatory reactions and hypoxic-ischemic damage rather than neuronal viral load. Older individuals are more likely to experience neurological symptoms.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Review Infectious Diseases

Long COVID, a comprehensive systematic scoping review

Hossein Akbarialiabad et al.

Summary: This study provides a review of literature on Long COVID until January 30, 2021, revealing controversies in its definition and predominant symptoms such as fatigue, breathlessness, and arthralgia. Potential long-term sequelae include cutaneous, respiratory, cardiovascular involvement, among others.

INFECTION (2021)

Review Neurosciences

A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development

Medha Karnik et al.

Summary: COVID-19 caused by SARS-CoV-2 is a devastating viral infection with higher mortality in older individuals and those with preexisting conditions. Understanding the virus entry mechanism and its impact on different organ systems is crucial for developing effective therapeutic strategies.

MOLECULAR NEUROBIOLOGY (2021)

Article Clinical Neurology

Long-term neurological manifestations of COVID-19: prevalence and predictive factors

Andrea Pilotto et al.

Summary: Long-term neurological manifestations have been observed in both hospitalised and non-hospitalised COVID-19 patients. Factors such as age, comorbidities, and severity of SARS-CoV-2 infection are independent predictors of long-term neurological symptoms in survivors after 6 months of hospitalisation.

NEUROLOGICAL SCIENCES (2021)

Article Multidisciplinary Sciences

More than 50 long-term effects of COVID-19: a systematic review and meta-analysis

Sandra Lopez-Leon et al.

Summary: This study aimed to identify studies assessing the long-term effects of COVID-19, estimating that 80% of infected patients will develop one or more long-term symptoms, with the most common being fatigue, headache, attention disorder, hair loss, and dyspnea.

SCIENTIFIC REPORTS (2021)

Article Environmental Sciences

Neuropsychological Pattern in a Series of Post-Acute COVID-19 Patients in a Rehabilitation Unit: Retrospective Analysis and Correlation with Functional Outcomes

Davide Antonio Di Pietro et al.

Summary: Intensive Care Unit delirium, insomnia, anxiety, and frontal/dysexecutive disorders have been reported following COVID-19 infection. A case study aimed to re-evaluate the neuropsychological pattern in patients recovering from COVID-19. Subclinical cognitive alterations were found in 4% of patients, highlighting the importance of proper cognitive evaluation and rehabilitation.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Clinical Neurology

Subacute Cognitive Impairment in Individuals With Mild and Moderate COVID-19: A Case Series

Aline de Moura Brasil Matos et al.

Summary: This study described seven cases from Brazil of outpatients with mild or moderate COVID-19 who developed subacute cognitive disturbances after recovery. The results suggest that these cognitive symptoms might be related to SARS-CoV-2-induced damage to cortico-subcortical associative pathways, rather than solely due to inflammation and hypoxia.

FRONTIERS IN NEUROLOGY (2021)

Review Infectious Diseases

Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments

Shin Jie Yong

Summary: Long COVID or post-COVID-19 syndrome is a poorly understood condition that affects survivors with symptoms like fatigue, dyspnoea, cognitive impairments, and more. The pathophysiology, risk factors, and treatments are still lacking in literature, but potential treatments may include rehabilitation training and repurposed drugs from similar conditions. Further research is needed to substantiate risk factors and treatment options.

INFECTIOUS DISEASES (2021)

Article Medicine, General & Internal

Cognitive deficits in people who have recovered from COVID-19

Adam Hampshire et al.

Summary: This study investigates cognitive deficits in individuals who have recovered from COVID-19, showing that even asymptomatic individuals exhibit significant cognitive impairments. This suggests a multi-domain impact of COVID-19 on human cognition.

ECLINICALMEDICINE (2021)

Article Medicine, General & Internal

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact

Hannah E. Davis et al.

Summary: Patients with Long COVID report prolonged, multisystem involvement and significant disability. By seven months, many patients have not yet recovered (mainly from systemic and neurological/cognitive symptoms), have not returned to previous levels of work, and continue to experience significant symptom burden.

ECLINICALMEDICINE (2021)

Article Health Care Sciences & Services

Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study

Max Augustin et al.

Summary: The study observed long-term symptoms in non-hospitalised patients post SARS-CoV-2 infection for four and seven months, identifying persistent symptoms such as shortness of breath, anosmia, ageusia, and fatigue, summarised as post-COVID syndrome (PCS).

LANCET REGIONAL HEALTH-EUROPE (2021)

Article Geriatrics & Gerontology

Impact of COVID-19: urging a need for multi-domain assessment of COVID-19 inpatients

Arne Heyns et al.

Summary: The study retrospectively analyzed the health status of hospitalized COVID-19 patients, finding high prevalence of physical, cognitive, psychological, and functional impairments, especially in ICU patients and older adults (>70 years). These results suggest the need for rehabilitation and follow-up for these patients.

EUROPEAN GERIATRIC MEDICINE (2021)

Review Respiratory System

Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

Kevin Cares-Marambio et al.

Summary: A systematic review found that the most prevalent respiratory symptoms in survivors of hospital admission by COVID-19 between 3 weeks and 3 months after discharge were fatigue, dyspnoea, chest pain, and cough, with prevalence rates of 52%, 37%, 16%, and 14% respectively.

CHRONIC RESPIRATORY DISEASE (2021)

Article Medicine, General & Internal

Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge

Betty Raman et al.

Summary: The study found that COVID-19 patients discharged from the hospital still experience breathlessness, fatigue, cognitive impairment, and mental health issues. MRI revealed abnormalities in multiple organs, which were linked to inflammation and severity of acute illness.

ECLINICALMEDICINE (2021)

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

Article Geriatrics & Gerontology

Psychological Distress and Its Correlates Among COVID-19 Survivors During Early Convalescence Across Age Groups

Xin Cai et al.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2020)

Article Psychology, Clinical

Post-traumatic stress disorder: a differential diagnostic consideration for COVID-19 survivors

Erin T. Kaseda et al.

CLINICAL NEUROPSYCHOLOGIST (2020)

Article Psychiatry

The landscape of cognitive function in recovered COVID-19 patients

Hetong Zhou et al.

JOURNAL OF PSYCHIATRIC RESEARCH (2020)

Editorial Material Mathematical & Computational Biology

Towards Neuro-CoViD-19

Francesco Chiappelli

BIOINFORMATION (2020)

Letter Endocrinology & Metabolism

Executive dysfunction in COVID-19 patients

Alfredo Ardila et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)

Review Critical Care Medicine

Review: Post-Intensive Care Syndrome: Unique Challenges in the Neurointensive Care Unit

Jamie Nicole LaBuzetta et al.

NEUROCRITICAL CARE (2019)

Review Engineering, Biomedical

Feasibility of Muscle Synergy Outcomes in Clinics, Robotics, and Sports: A Systematic Review

Juri Taborri et al.

APPLIED BIONICS AND BIOMECHANICS (2018)

Article Medicine, General & Internal

PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation

Andrea C. Tricco et al.

ANNALS OF INTERNAL MEDICINE (2018)

Review Medicine, General & Internal

Post-intensive care syndrome: An overview

Gautam Rawal et al.

JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE (2017)

Article Critical Care Medicine

Posttraumatic Stress Disorder in Critical Illness Survivors: A Metaanalysis

Ann M. Parker et al.

CRITICAL CARE MEDICINE (2015)

Article Critical Care Medicine

The Adult Respiratory Distress Syndrome Cognitive Outcomes Study Long-Term Neuropsychological Function in Survivors of Acute Lung Injury

Mark E. Mikkelsen et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)

Article Critical Care Medicine

Self-reported Depressive Symptoms and Memory Complaints in Survivors Five Years After ARDS

Neill K. J. Adhikari et al.

CHEST (2011)

Article Psychiatry

Risk factors for depression and anxiety in survivors of acute respiratory distress syndrome

Ramona O. Hopkins et al.

GENERAL HOSPITAL PSYCHIATRY (2010)

Article Health Care Sciences & Services

Scoping studies: advancing the methodology

Danielle Levac et al.

IMPLEMENTATION SCIENCE (2010)

Article Critical Care Medicine

Six-month neuropsychological outcome of medical intensive care unit patients

JC Jackson et al.

CRITICAL CARE MEDICINE (2003)